Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Shadi Haddadin (NPI 1073611919)

Field	Value
Entity Type	Individual
Organization	Shadi Haddadin
Address	1241 W Stadium Blvd
City	Jefferson City
State	MO
ZIP	65109
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	September 21, 2006

Payer Source	Total Paid
Medicare	$2.2M
Medicaid	$0

Key Findings

SHADI HADDADIN is a Hematology & Oncology Physician with NPI enumerated on 2006-09-21 (~20 years ago). Lifetime Medicare revenue on file is $2.2M and there is no Medicaid billing on file, indicating this provider’s billing footprint is effectively single‑payer (Medicare) in the datasets available.

Revenue is highly concentrated in a small number of high-cost drug administrations: the precomputed top three Medicare codes account for 74.9% of this provider’s total Medicare revenue. Those top three codes are J9271 ($1.1M, 50.8%), J1556 ($301.5K, 13.9%), and J0897 ($221.4K, 10.2%), showing that a few biologic/infusion products drive the bulk of income.

The code mix is consistent with an infusion-based oncology practice: J9271 (pembrolizumab) is a high-revenue checkpoint inhibitor used in cancer immunotherapy, J1556 (immune globulin) indicates frequent IV immunoglobulin administrations, and J0897 (denosumab) supports bone-health management common in oncology/hematology care. Together with chemotherapy administration codes and multiple infusion add-ons in the top 25, the pattern points to on-site drug administration and infusion services as central to operations.

Despite accounting for half the Medicare revenue, J9271 is ranked #213 of 1841 providers nationally (88th percentile) and is labeled in the raw data as a "typical, unremarkable volume for this code," implying the provider’s pembrolizumab billing is significant in revenue but not anomalously high relative to national oncology peers.

J1556 and J0897 show different competitive signals: J1556 is ranked #27 of 46 providers nationally (42th percentile; typical, unremarkable volume for this code), reflecting a small national peer group and middling position, while J0897 is ranked #793 of 10057 providers nationally (92th percentile; typical, unremarkable volume for this code), which indicates relatively high national activity on denosumab compared with most peers.

Evaluation-and-management (E/M) volumes are notable outliers: 99214 generated $102.7K (4.7% of Medicare revenue) and 99213 generated $58.4K (2.7%), and both codes are described as "extreme outlier, far above typical national volume for this code." This suggests an unusually high throughput of established outpatient visits relative to national norms, consistent with intensive longitudinal outpatient management of oncology patients.

Procedure and infusion support codes further emphasize infusion workload: 96413 (chemotherapy administration) produced $57.1K (2.6%) and is ranked #371 of 7514 providers nationally (95th percentile; notably above typical national volume for this code), and multiple infusion-related codes (96375, 96367, 96360, 96365, 96417) also appear in the top 25 with labels ranging from "notably above typical" to "typical, unremarkable." This combination points to meaningful procedural throughput beyond drug costs, reinforcing an infusion-clinic operational profile.

Taken together, the provider appears to be an established, Medicare-focused oncology practice with $2.2M in lifetime Medicare revenue concentrated heavily in a few high-cost biologic/infusion codes (top 3 = 74.9%). The absence of Medicaid billing on file makes payer diversification limited in the available records, so shifts in Medicare policy or drug utilization could materially affect this provider’s revenue mix.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

69 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	25,600	$40	$1.1M
J1556	Injection, immune globulin (bivigam), 500 mg	5,290	$60	$301.5K
J0897	Injection, denosumab, 1 mg	12,300	$20	$221.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,140	$90	$102.7K
J1437	Injection, ferric derisomaltose, 10 mg	5,800	$20	$92.8K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	3,900	$20	$89.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	990	$60	$58.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	630	$90	$57.1K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	2,350	$10	$18.8K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	1,160	$10	$12.8K

Showing 1–10 of 69

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 69 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Shadi Haddadin — 14 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

69 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	6	40	9,100	$40	$502K
J1556	1	10	3,980	$60	$225.1K
J0897	17	210	2,400	$20	$82.4K
Q5119	1	10	1,570	$20	$43.6K
J1437	1	10	2,500	$20	$43.5K
Q5106	4	10	5,270	$10	$28.3K
96413	10	160	140	$100	$19.1K
J3490	3	80	40	$150	$14K
J0185	8	10	9,490	$1	$14K
99214	79	8,960	100	$80	$13.9K

Showing 1–10 of 69

Related Providers

Other providers that share a Tax Identification Number (TIN) with Shadi Haddadin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Community Hospices Of America, LLC	MO	Community Based Hospice Care Agency	$0	$5.5M
Community Hospices Of America, LLC	MO	Community Based Hospice Care Agency	$0	$4M
Stephen Sides	MO	Rheumatology Physician	$2.9M	$0
Tamara Hopkins	MO	Hematology & Oncology Physician	$887.1K	$0
Thomas Schneider	MO	Pulmonary Disease Physician	$411.2K	$0
Michael Snyder	MO	Orthopaedic Surgery Physician	$320.1K	$0
Jonathan Craighead	MO	Orthopaedic Surgery Physician	$259.6K	$0
Philip Rumbaoa	MO	Phlebology Physician	$257.7K	$0
Stephanie Hose	MO	Dermatology Physician	$222.7K	$0
Indumathi Baskar	MO	Internal Medicine Physician	$218.4K	$0

Nearby Providers

Other providers in the same ZIP code as Shadi Haddadin, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
State Of Missouri	MO	Rehabilitation Counselor	$0	$160.2M
Help At Home, LLC	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$97M
Ssm Regional Health Services	MO	General Acute Care Hospital	$0	$20.8M
Rehab Specialty Medical, Inc.	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$19.7M
Day Solutions, Inc	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$14M
Skillset LLC	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$11.6M
Independent Living Resource Center, Inc.	MO	Home Health Agency	$0	$8.3M
Tiffany Burns	MO	Student in an Organized Health Care Education/Training Program	$0	$7.7M
County Of Cole	MO	Land Ambulance	$809.3K	$5.2M
Jcmg Surgery Center, Inc.	MO	Ambulatory Surgical Clinic/Center	$1.2M	$0

Shadi Haddadin — Billing Profile & Reimbursement Data

Sign up for Shadi Haddadin — Billing Profile & Reimbursement Data policy alerts

Shadi Haddadin — Billing Profile & Reimbursement Data

Sign up for Shadi Haddadin — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References